Zynerba Pharmaceuticals (ZYNE) Leaps Despite Expected Loss

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares gained 4.1% to $20.45, as the company is estimated to report a quarterly loss at $0.74 per share. Share volume was 266,000, compared to an all-day average of 450,000